These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3010633)

  • 1. Combined hepatocellular and mucinous carcinoma.
    Wada K; Kondo F; Kubosawa H; Kondo Y
    Acta Pathol Jpn; 1986 Feb; 36(2):285-91. PubMed ID: 3010633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular carcinoma and cholangiocarcinoma with components of mucinous carcinoma arising in a cirrhotic liver.
    Morita D; Kagata Y; Ogata S; Tsuda H; Hatsuse K; Mochizuki H; Matsubara O
    Pathol Int; 2006 Apr; 56(4):222-6. PubMed ID: 16634969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hepatocellular and cholangiocarcinoma arising in a cirrhotic liver. Report of an autopsy case.
    Sonobe H; Hayashi K; Takahashi K; Ohtsuki Y; Matsumoto K; Onishi S; Jinno K
    Acta Pathol Jpn; 1987 Dec; 37(12):1945-52. PubMed ID: 2833062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoglandular hepatocellular carcinoma. A morphogenetic study.
    Kondo Y; Nakajima T
    Cancer; 1987 Sep; 60(5):1032-7. PubMed ID: 2440554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicomorphological manifestations of primary liver carcinoma (PLC) in liver cirrhosis.
    Ferlan-Marolt V; Markovic S
    Cancer Detect Prev; 1986; 9(5-6):491-3. PubMed ID: 3022928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathologic features and diagnosis of mixed type hepatocellular carcinoma].
    Lu J; Lin Z; Yuan S
    Zhonghua Zhong Liu Za Zhi; 1995 May; 17(3):208-11. PubMed ID: 7656828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of mucinous cholangiocarcinoma showing features of hepatocellular carcinoma.
    Kai K; Ide Y; Miyoshi A; Masuda M; Ide T; Kitahara K; Irie H; Nakajima J; Noshiro H; Tokunaga O
    Pathol Int; 2013 Aug; 63(8):419-21. PubMed ID: 23957918
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver carcinoma and liver fluke infection.
    Kim YI
    Arzneimittelforschung; 1984; 34(9B):1121-6. PubMed ID: 6095876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic features of fibrolamellar carcinoma with mucin production: a rare variant of combined hepatocellular-cholangiocarcinoma.
    Rosa M; Mohammadi A
    Diagn Cytopathol; 2014 May; 42(5):431-5. PubMed ID: 23008149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a hepatocellular lineage in a combined hepatocellular-cholangiocarcinoma of transitional type.
    Fisher HP; Doppl W; Osborn M; Altmannsberger M
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 56(2):71-6. PubMed ID: 2467436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma) in Japan.
    Tomimatsu M; Ishiguro N; Taniai M; Okuda H; Saito A; Obata H; Yamamoto M; Takasaki K; Nakano M
    Cancer; 1993 Aug; 72(3):683-8. PubMed ID: 8192727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of sarcomatoid combined hepatocellular-cholangiocarcinoma].
    Jeong BJ; Hyun DH; Lee KW; Ryu ST; Lee JW; Lee JI; Jeong S; Lee DH; Kim PS; Kim HG; Kim YS; Kim JM
    Korean J Gastroenterol; 2004 Jan; 43(1):56-60. PubMed ID: 14745254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perihilar cholangiocarcinoma arising in hepatitis C virus-related liver cirrhosis with hepatocellular carcinoma.
    Fujii T; Zen Y; Nakanuma Y
    J Gastroenterol; 2007 Aug; 42(8):698-702. PubMed ID: 17701135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An autopsy case with a combination of hepatocellular carcinoma and cholangiocellular carcinoma].
    Sugihara S; Nakahara T; Maruiwa M; Kojiro M; Iwai I; Tanaka M; Hirai K; Majima Y; Tanikawa K
    Gan No Rinsho; 1987 Feb; 33(2):205-10. PubMed ID: 3031334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
    Xu J; Zhang C; Qiao A; Xi Y
    Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years.
    Nakashima T; Okuda K; Kojiro M; Jimi A; Yamaguchi R; Sakamoto K; Ikari T
    Cancer; 1983 Mar; 51(5):863-77. PubMed ID: 6295617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucin-hypersecreting bile duct tumor characterized by a striking homology with an intraductal papillary mucinous tumor (IPMT) of the pancreas.
    Kim HJ; Kim MH; Lee SK; Yoo KS; Park ET; Lim BC; Park HJ; Myung SJ; Seo DW; Min YI
    Endoscopy; 2000 May; 32(5):389-93. PubMed ID: 10817178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
    Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
    Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.